The Procter & Gamble Company
PG · NYSE
6/30/2025 | 6/30/2024 | 6/30/2023 | 6/30/2022 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | 3.09 | 14.24 | 21.02 | 4.40 |
| FCF Yield | 3.59% | 4.30% | 3.84% | 3.84% |
| EV / EBITDA | 17.43 | 18.06 | 17.75 | 17.81 |
| Quality | ||||
| ROIC | 16.47% | 15.39% | 15.24% | 15.75% |
| Gross Margin | 51.16% | 51.39% | 47.86% | 47.43% |
| Cash Conversion Ratio | 1.11 | 1.33 | 1.14 | 1.13 |
| Growth | ||||
| Revenue 3-Year CAGR | 0.92% | 1.58% | 2.51% | 4.16% |
| Free Cash Flow Growth | -15.01% | 19.86% | 1.61% | -12.94% |
| Safety | ||||
| Net Debt / EBITDA | 1.08 | 1.06 | 1.25 | 1.18 |
| Interest Coverage | 22.55 | 20.05 | 23.99 | 40.58 |
| Efficiency | ||||
| Inventory Turnover | 5.45 | 5.82 | 6.05 | 6.09 |
| Cash Conversion Cycle | -41.28 | -48.02 | -39.88 | -45.49 |